Some 20,000 Rejuvenate and ABG II hip stems had been sold worldwide by the time the Stryker Rejuvenate recall was announced in July 2012. Brought to market in 2009, the Rejuvenate and ABG II hip stems have a modular design that offered surgeons the option to choose components of various sizes, resulting in a custom fit for each particular patient. The components involved in the 2012 Stryker Rejuvenate hip implant recall were marketed to younger, more active patients with promises that they would last longer than other artificial hips. Unfortunately, those promises have fallen short.
According to the Stryker Rejuvenate hip replacement recall notice, the Rejuvenate and ABG II hip stems are prone to fretting and corrosion at the modular-neck junction. As such, the hips can generate excessive amounts of metallic debris, which can leach into the surrounding tissue, and even make their way into the blood stream. According to Stryker, patients with the recalled Rejuvenate hip components are at risk for swelling, pain and adverse local tissue reactions. Patients affected by the Stryker Rejuvenate recall have been advised to undergo metal ion blood testing and imaging screenings, even if they are not experiencing problems with their hip.